MedPath

Effects of Dexmedetomidine on Quality of Recovery and Analgesia After Video-assisted Thoracoscopic Surgery

Not Applicable
Completed
Conditions
Lung Cancer
Video-assisted Thoracoscopic Surgery
Interventions
Drug: Normal saline
Drug: Dexmedetomidine
Registration Number
NCT02537249
Lead Sponsor
Yonsei University
Brief Summary

Dexmedetomidine is a selective α2 adrenergic agonist that can be considered analgesics, anxiolytic,and anti-stress effect . This randomized, double-blind placebo-controlled trial of intraoperative dexmedetomidine for improvement of quality of recovery and analgesia from surgery. Patients scheduled to undergo video-assisted thoracoscopic surgery (VATS) will be enrolled. Patients will be recruited before the date of their surgery and will complete the Quality of Recovery-40 (QoR-40) questionnaire before their surgery and at 24 and 48 hours post op. They will also complete clinically significant pains score and oxygenation from the postanesthetic recovery unit (PACU).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
111
Inclusion Criteria
  1. The inclusion criteria included patients scheduled video-assisted thoracoscopic surgery for lung cancer
  2. Adults above 20 years of age and providing informed consent.
  3. American Society of Anesthesiologists (ASA) Physical class II, & III patients
Read More
Exclusion Criteria
  1. severe functional liver or kidney disease
  2. history of chronic pain requiring opioid treatment
  3. arrhythmia or received treatment with antiarrythmic drug .
  4. severe bradycardia (HR < 45 bpm) and AV block
  5. pathologic esophageal lesion (esophageal stricture or varix )
  6. pregnancy
  7. psychiatric/central nervous system disturbance that would preclude completion of the QoR-40 questionnaire
  8. History of alcohol or drug abuse
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Saline 0.9%Normal saline-
DexmedetomidineDexmedetomidine-
Primary Outcome Measures
NameTimeMethod
quality of recovery measured by QoR-40 questionnaire24 hr after operation
pulmonary function test24 hr after operation

postoperative lung function assessed by spirometry

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath